FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

420627008: Extended-release tablet (qualifier value)

    Status: retired, Primitive. Date: 31-Jan 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2616687018 Extended-release tablet en Synonym Active Case insensitive SNOMED CT core
    2660656013 Extended-release tablet (qualifier value) en Fully specified name Active Case insensitive SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Extended-release tablet Is a Conventional release oral tablet false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Prolonged-release film-coated oral tablet Is a False Extended-release tablet Inferred relationship Some
    Gastro-resistant and prolonged-release oral tablet Is a False Extended-release tablet Inferred relationship Some
    Paliperidone 9 mg prolonged-release oral tablet Has manufactured dose form False Extended-release tablet Inferred relationship Some
    Paliperidone 6 mg prolonged-release oral tablet Has manufactured dose form False Extended-release tablet Inferred relationship Some
    Paliperidone 3 mg prolonged-release oral tablet Has manufactured dose form False Extended-release tablet Inferred relationship Some
    Paliperidone 1.5 mg prolonged-release oral tablet Has manufactured dose form False Extended-release tablet Inferred relationship Some
    Amoxicillin 775mg extended release tablet Has manufactured dose form False Extended-release tablet Inferred relationship Some
    Quetiapine (as quetiapine fumarate) 300 mg prolonged-release oral tablet Has manufactured dose form False Extended-release tablet Inferred relationship Some
    Quetiapine (as quetiapine fumarate) 200 mg prolonged-release oral tablet Has manufactured dose form False Extended-release tablet Inferred relationship Some
    Quetiapine (as quetiapine fumarate) 400 mg prolonged-release oral tablet Has manufactured dose form False Extended-release tablet Inferred relationship Some
    Zileuton 600 mg prolonged-release oral tablet Has manufactured dose form False Extended-release tablet Inferred relationship Some
    Bupropion hydrobromide 348 mg prolonged-release oral tablet Has manufactured dose form False Extended-release tablet Inferred relationship Some
    Bupropion hydrobromide 174 mg prolonged-release oral tablet Has manufactured dose form False Extended-release tablet Inferred relationship Some
    Guanfacine hydrochloride 4mg extended release tablet Has manufactured dose form False Extended-release tablet Inferred relationship Some
    Guanfacine hydrochloride 3mg extended release tablet Has manufactured dose form False Extended-release tablet Inferred relationship Some
    Guanfacine hydrochloride 1mg extended release tablet Has manufactured dose form False Extended-release tablet Inferred relationship Some
    Nicotinic acid 250 mg prolonged-release oral tablet Has manufactured dose form False Extended-release tablet Inferred relationship Some
    Ropinirole (as ropinirole hydrochloride) 8 mg prolonged-release oral tablet Has manufactured dose form False Extended-release tablet Inferred relationship Some
    Guanfacine hydrochloride 2mg extended release tablet Has manufactured dose form False Extended-release tablet Inferred relationship Some
    Ropinirole (as ropinirole hydrochloride) 2 mg prolonged-release oral tablet Has manufactured dose form False Extended-release tablet Inferred relationship Some
    Ropinirole (as ropinirole hydrochloride) 4 mg prolonged-release oral tablet Has manufactured dose form False Extended-release tablet Inferred relationship Some
    Ropinirole 3mg extended release tablet Has manufactured dose form False Extended-release tablet Inferred relationship Some
    Levetiracetam 500 mg prolonged-release oral tablet Has manufactured dose form False Extended-release tablet Inferred relationship Some
    Bupropion hydrobromide 522 mg prolonged-release oral tablet Has manufactured dose form False Extended-release tablet Inferred relationship Some
    Potassium chloride 1.5 g prolonged-release oral tablet Has manufactured dose form False Extended-release tablet Inferred relationship Some
    Pramipexole dihydrochloride 375 microgram prolonged-release oral tablet Has manufactured dose form False Extended-release tablet Inferred relationship Some
    Pramipexole dihydrochloride 750 microgram prolonged-release oral tablet Has manufactured dose form False Extended-release tablet Inferred relationship Some
    Pramipexole dihydrochloride 1.5 mg prolonged-release oral tablet Has manufactured dose form False Extended-release tablet Inferred relationship Some
    Trazodone hydrochloride 300 mg prolonged-release oral tablet Has manufactured dose form False Extended-release tablet Inferred relationship Some
    Trazodone hydrochloride 150 mg prolonged-release oral tablet Has manufactured dose form False Extended-release tablet Inferred relationship Some
    Fampridine 10 mg prolonged-release oral tablet Has manufactured dose form False Extended-release tablet Inferred relationship Some
    Pramipexole dihydrochloride 4.5 mg prolonged-release oral tablet Has manufactured dose form False Extended-release tablet Inferred relationship Some
    Pramipexole dihydrochloride 3 mg prolonged-release oral tablet Has manufactured dose form False Extended-release tablet Inferred relationship Some
    Nevirapine 400 mg prolonged-release oral tablet Has manufactured dose form False Extended-release tablet Inferred relationship Some
    Metformin hydrochloride 500 mg and saxagliptin (as saxagliptin hydrochloride) 5 mg prolonged-release oral tablet Has manufactured dose form False Extended-release tablet Inferred relationship Some
    Metformin hydrochloride 1 g and saxagliptin (as saxagliptin hydrochloride) 5 mg prolonged-release oral tablet Has manufactured dose form False Extended-release tablet Inferred relationship Some
    Metformin hydrochloride 1 g and saxagliptin (as saxagliptin hydrochloride) 2.5 mg prolonged-release oral tablet Has manufactured dose form False Extended-release tablet Inferred relationship Some

    Reference Sets

    Concept inactivation indicator reference set

    SAME AS association reference set

    Back to Start